학술논문
Inflammatory Myopathies: Utility of Antibody Testing.
Document Type
Academic Journal
Author
Biliciler S; Department of Neurology, UT Health Science Center in Houston, McGovern Medical School, 6341 Fannin Street, MSC #466, Houston, TX 77030, USA. Electronic address: suur.biliciler@uth.tmc.edu.; Kwan J; Department of Neurology, Temple University, Lewis Katz School of Medicine, 3401 North Broad Street Street, Suite C525, Philadelphia, PA 19410, USA.
Source
Publisher: Saunders Country of Publication: United States NLM ID: 8219232 Publication Model: Print Cited Medium: Internet ISSN: 1557-9875 (Electronic) Linking ISSN: 07338619 NLM ISO Abbreviation: Neurol Clin Subsets: MEDLINE
Subject
Language
English
Abstract
Inflammatory myopathies are a group of immune-mediated muscle disorders comprising dermatomyositis; polymyositis; overlap myositis, including antisynthetase syndromes and nonspecific myositis, immune-mediated necrotizing myopathies, and sporadic inclusion body myositis. They are now much more eloquently classified both pathologically and clinically because of the discovery of several myositis-specific and myositis-associated antibodies. These antibodies also aid in choosing the best treatment options in each case. Based on the initial classifications of inflammatory myopathies, inclusion body myositis, overlap myositis, and necrotizing myositis were all included in the polymyositis group. This article discusses cases, diagnostic tools, associated antibodies, and pathology.
(Published by Elsevier Inc.)
(Published by Elsevier Inc.)